
Overview
Alan Marks is an Ophthalmologist in New Hyde Park, New York. Dr. Marks is rated as an Experienced provider by MediFind in the treatment of Nearsightedness. His top areas of expertise are Cataract, Blepharitis, Eyelid Bump, and Meibomianitis.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- PPO
- INSURANCE PLAN
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Quan Hoang is an Ophthalmologist in New York, New York. Dr. Hoang is rated as a Distinguished provider by MediFind in the treatment of Nearsightedness. His top areas of expertise are Nearsightedness, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.
Anastasios Kanellopoulos is an Ophthalmologist in New York, New York. Dr. Kanellopoulos is rated as an Elite provider by MediFind in the treatment of Nearsightedness. His top areas of expertise are Keratoconus, Astigmatism, Nearsightedness, Cataract Removal, and Corneal Transplant.
Vitreous Retina Macula Consultants Of New York
Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide. Dr. Yannuzzi is rated as a Distinguished provider by MediFind in the treatment of Nearsightedness. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- CataractDr. Marks isDistinguished. Learn about Cataract.
- Advanced
- Age-Related Macular Degeneration (ARMD)
- BlepharitisDr. Marks isAdvanced. Learn about Blepharitis.
- ChalazionDr. Marks isAdvanced. Learn about Chalazion.
- Eyelid BumpDr. Marks isAdvanced. Learn about Eyelid Bump.
- Late-Onset Retinal DegenerationDr. Marks isAdvanced. Learn about Late-Onset Retinal Degeneration.
- MeibomianitisDr. Marks isAdvanced. Learn about Meibomianitis.
- Experienced
- Blocked Tear DuctDr. Marks isExperienced. Learn about Blocked Tear Duct.
- Choroid Plexus CarcinomaDr. Marks isExperienced. Learn about Choroid Plexus Carcinoma.
- Conjunctivitis (Pink Eye)Dr. Marks isExperienced. Learn about Conjunctivitis (Pink Eye).
- Dry Eye SyndromeDr. Marks isExperienced. Learn about Dry Eye Syndrome.
- GlaucomaDr. Marks isExperienced. Learn about Glaucoma.
- Graves DiseaseDr. Marks isExperienced. Learn about Graves Disease.

